Reply to: 'Clinical efficacy and safety of cefiderocol in the treatment of acute bacterial infections: a systematic review and meta-analysis of randomised controlled trials'

J Glob Antimicrob Resist. 2021 Sep:26:342-343. doi: 10.1016/j.jgar.2021.05.007. Epub 2021 Jun 10.

Authors

P Clevenbergh¹, E Maillart¹, P M Tulkens²

Affiliations

¹ Infectious Diseases Clinic, CHU Brugmann, Brussels, Belgium.
² Cellular and Molecular Pharmacology, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.

PMID: 34118480
DOI: 10.1016/j.jgar.2021.05.007

No abstract available

Publication types

Letter
Comment

MeSH terms

Bacterial Infections* / drug therapy
Cefiderocol
Cephalosporins* / therapeutic use
Humans
Treatment Outcome

Substances

Cephalosporins